Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Prenat Diagn ; 23(9): 701-4, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12975777

ABSTRACT

X-linked dominant chondrodysplasia punctata, (CDPX2-MIM302960) also known as Conradi-Hünermann-Happle syndrome, is a rare form of skeletal dysplasia that affects the skeleton, skin, hair, and eyes. The disorder is caused by mutations within the emopamil binding protein (Ebp) that functions as a delta(8), delta(7) sterol isomerase in the cholesterol biosynthesis pathway. To date, over 40 separate mutations have been reported in the Ebp gene, EBP, with no obvious correlation between the molecular defects and the severity of the clinical phenotype. We have studied a 30-year-old woman who presented in adulthood with skin, hair, and mild skeletal defects but no ocular abnormalities and have identified a heterozygous missense mutation within the third transmembrane domain of the protein. In addition, we have performed molecular prenatal testing on her unborn fetus. The results demonstrate inter-familial variability for missense mutations within the emopamil binding protein and add to the molecular data for CDPX2.


Subject(s)
Chondrodysplasia Punctata/genetics , Chromosomes, Human, X/genetics , Genetic Testing , Prenatal Diagnosis , Adult , Biomarkers , Cholesterol/metabolism , Chondrodysplasia Punctata/blood , DNA Primers , Diagnosis, Differential , Female , Humans , Lipid Metabolism, Inborn Errors/blood , Lipid Metabolism, Inborn Errors/genetics , Mutation , Pedigree , Polymerase Chain Reaction , Pregnancy
4.
Sex Transm Infect ; 75(5): 291-3, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10616350

ABSTRACT

Eosinophilic folliculitis (EF) is a chronic, intensely pruritic condition of unknown pathogenesis that causes marked morbidity in those HIV patients whom it affects. There is a wide differential diagnosis of itchy skin conditions in HIV which are amenable to different treatments. It is therefore essential to take a biopsy of each suspected case and examine multiple sections of the biopsy to confirm or refute a diagnosis of EF. Treatment of EF can be difficult but we hope that by suggesting a rational approach to this and considering possible therapeutic options more patients may be helped with this troublesome dermatosis.


Subject(s)
Eosinophilia/virology , Folliculitis/virology , HIV Infections/complications , Skin Diseases/virology , Administration, Topical , Anti-Infective Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Antifungal Agents/therapeutic use , Eosinophilia/pathology , Eosinophilia/therapy , Folliculitis/pathology , Folliculitis/therapy , Glucocorticoids , HIV Infections/pathology , Histamine H1 Antagonists/therapeutic use , Humans , Insecticides/therapeutic use , Isotretinoin/therapeutic use , Itraconazole/therapeutic use , Keratolytic Agents/therapeutic use , Metronidazole/therapeutic use , Permethrin , Pyrethrins/therapeutic use , Skin Diseases/pathology , Skin Diseases/therapy , Ultraviolet Therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...